These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4268858

  • 1. 5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.
    Marcialis MA, Biondi E, Atzeni A, Schivo ML, Uccheddu P, Loddo B.
    Experientia; 1973 Jun 15; 29(6):733-4. PubMed ID: 4268858
    [No Abstract] [Full Text] [Related]

  • 2. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.
    Smee DF, Humphreys DE, Hurst BL, Barnard DL.
    Antivir Chem Chemother; 2008 Jun 15; 19(1):15-24. PubMed ID: 18610554
    [Abstract] [Full Text] [Related]

  • 3. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
    Jamieson AT, Gentry GA, Subak-Sharpe JH.
    J Gen Virol; 1974 Sep 15; 24(3):465-80. PubMed ID: 4372299
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine.
    Kodama E, Mori S, Shigeta S.
    Antiviral Res; 1995 May 15; 27(1-2):165-70. PubMed ID: 7486953
    [Abstract] [Full Text] [Related]

  • 5. Properties of 5-bromodeoxyuridine-resistant lines of higher plant cells in liquid culture.
    Ohyama K.
    Exp Cell Res; 1974 Nov 15; 89(1):31-8. PubMed ID: 4279827
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.
    Shigeta S, Mori S, Yokota T, Konno K, De Clercq E.
    Antimicrob Agents Chemother; 1986 Jun 15; 29(6):1053-8. PubMed ID: 3015014
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
    Herrmann EC.
    Appl Microbiol; 1968 Aug 15; 16(8):1151-5. PubMed ID: 4300089
    [Abstract] [Full Text] [Related]

  • 8. Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.
    Teich N, Lowy DR, Hartley JW, Rowe WP.
    Virology; 1973 Jan 15; 51(1):163-73. PubMed ID: 4346294
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
    Gati WP, Knaus EE, Wiebe LI.
    Mol Pharmacol; 1983 Jan 15; 23(1):146-52. PubMed ID: 6223203
    [Abstract] [Full Text] [Related]

  • 10. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J, De Clercq E, Verbruggen A, Ayusawa D, Shimizu K, Seno T.
    Mol Pharmacol; 1987 Sep 15; 32(3):410-6. PubMed ID: 2823092
    [Abstract] [Full Text] [Related]

  • 11. Differences in thymidine kinase-inducing ability of herpesvirus types 1 and 2.
    Lowry SP, Bresnick E, Rawls WE.
    Virology; 1971 Dec 15; 46(3):958-61. PubMed ID: 5002940
    [No Abstract] [Full Text] [Related]

  • 12. Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.
    Cheng YC, Dutschman G, De Clercq E, Jones AS, Rahim SG, Verhelst G, Walker RT.
    Mol Pharmacol; 1981 Jul 15; 20(1):230-3. PubMed ID: 6270535
    [No Abstract] [Full Text] [Related]

  • 13. PROPERTIES OF DEOXYTHYMIDINE KINASE PARTIALLY PURIFIED FROM NONINFECTED MOUSE FIBROBLAST CELLS.
    KIT S, DUBBS DR.
    Virology; 1965 May 15; 26():16-27. PubMed ID: 14293309
    [No Abstract] [Full Text] [Related]

  • 14. Incorporation of idoxuridine analogs into corneal herpes simplex virus.
    Hanna C.
    Ann Ophthalmol; 1972 Nov 15; 4(11):991-6. PubMed ID: 4265776
    [No Abstract] [Full Text] [Related]

  • 15. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T, Konno K, Shigeta S, Verbruggen A, De Clercq E.
    Mol Pharmacol; 1987 May 15; 31(5):493-9. PubMed ID: 3033468
    [Abstract] [Full Text] [Related]

  • 16. [Decrease of the pathogenic action on rabbit skin of vaccinia virus made resistant to 5-iodo-desoxyuridine].
    Gessa GL, Loddo B, Schivo ML.
    Boll Soc Ital Biol Sper; 1965 May 31; 41(10):535-7. PubMed ID: 5875593
    [No Abstract] [Full Text] [Related]

  • 17. Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
    Mathews CK.
    Exp Cell Res; 1975 Apr 31; 92(1):39-46. PubMed ID: 124255
    [No Abstract] [Full Text] [Related]

  • 18. Synergistic effect of 5'-amino-5'-deoxythymidine and 5-iodo-2'-deoxyuridine against Herpes Simplex virus infections in vitro.
    Fischer PH, Lee JJ, Chen MS, Lin TS, Prusoff WH.
    Biochem Pharmacol; 1979 Dec 01; 28(23):3483-6. PubMed ID: 231443
    [No Abstract] [Full Text] [Related]

  • 19. Characteristics of spontaneous and induced thymidine and 5-iodo-2-deoxyuridine resistant clones of mouse lymphoma cells.
    Fox M, Anderson D.
    Mutat Res; 1974 Oct 01; 25(1):89-105. PubMed ID: 4530153
    [No Abstract] [Full Text] [Related]

  • 20. Isolation and characterisation of Chinese hamster cells resistant to 5-fluorodeoxyuridine.
    Slack C, Morgan RH, Carritt B, Goldfarb PS, Hooper ML.
    Exp Cell Res; 1976 Mar 01; 98(1):1-14. PubMed ID: 130246
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.